analitik
Bugüne Kadar Yükseltildi: $147,972
Toplam Taahhütler $
Toplam: $' + total_amount_formatted + '
'; dönüş(vurgulu); }, yeniden boyutlandır: true, smooth : false, VerticalGrid: true }); jQuery('#analytics-tabs').on('change.zf.tabs', function(e) { if(jQuery('#deal_basics:visible').length){ totalChart.redraw(); jQuery(window) .trigger('yeniden boyutlandır'); } }); });
Net sermaye
10/03/2019
04/28/2020
$10,000
$1,070,000
$4
Hisse Senedi – Ortak
RegCF
Tohum
$19,621,196
Haddeleme Taahhütleri $
Önceki dönem: $' + haftalık_amount_formatted + '
'; dönüş(vurgulu); }, yeniden boyutlandır: true, smooth : false, VerticalGrid: true }); jQuery('#analytics-tabs').on('change.zf.tabs', function(e) { if(jQuery('#investment_momentum:visible').length){weekChart.redraw(); jQuery(window) .trigger('yeniden boyutlandır'); } }); });
finanse
05/03/2020
finanse
%1,480
%14
finanse
$711
finanse
Lokasyon
Sağlık ve İlaç
biyoteknoloji
B2B
Yüksek
Yüksek
Yüksek büyüme
SelenBio, a biotechnology company with a post-money valuation of $20.7 million, is raising funds on NetCapital. The company develops an antibacterial technology that prevents the formation of biofilm in dental, medical, industrial, and consumer applications. SelenBio uses a unique selenium-based compound, SELDOX, to keep the applications infection-free. The company was founded by Kenny Gallagher and Karl Doenges. The proceeds of the current crowdfunding round, with a minimum target of $10,000 and a maximum target of $1,070,000, will be used for research & development, operations, completion of current projects, sales & marketing, and compensation for managers. SelenBio is working on multiple projects with excellent traction and has already received the FDA approval for SELDOX.
Özet Kar ve Zarar Tablosu
|
Gelir |
$12,142 |
$1,039 |
|
SMM |
$11,785 |
$871 |
|
Vergi |
$0 |
$0 |
|
|
||
|
|
||
|
Net gelir |
$ -453,939 |
$ -134,867 |
Özet Bilanço
|
Nakit |
$550,794 |
$104,479 |
|
Alacak hesabı |
$153 |
$213 |
|
Toplam Varlıklar |
$1,044,713 |
$475,538 |
|
Kısa vadeli borç |
$0 |
$0 |
|
Uzun vadeli borç |
$0 |
$0 |
|
Toplam yükümlülükler |
$0 |
$0 |
Source: https://www.crowditz.com/2019/10/selenbio-on-netcapital/
